Need help? Our team of experienced experts is here for you with full support.
AKA-393
AktiAmino™ Fmoc-L-Glu(OtBu)-OH
Cat. No.
AKA-393
CAS No.
71989-18-9
MF
C24H27NO6
MW
425.48
AktiAmino™ Fmoc-L-Glu(OtBu)-OH is a doubly protected L-glutamic acid derivative used to introduce L-glutamic acid residues in solid-phase peptide synthesis. Fmoc protects the α-amino group, the side-chain γ-carboxyl group is protected as a tert-butyl ester, and the α-carboxyl group remains free.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
AktiAmino™ Fmoc-L-Glu(OtBu)-OH
CAS No.
71989-18-9
MF
C24H27NO6
MW
425.48
Specification
99%
Documents
Certificate of Analysis (COA), Specification sheet, Safety Data Sheet (SDS/MSDS) etc.
Description
AktiAmino™ Fmoc-L-Glu(OtBu)-OH is a doubly protected L-glutamic acid derivative used to introduce L-glutamic acid residues in solid-phase peptide synthesis. Fmoc protects the α-amino group, the side-chain γ-carboxyl group is protected as a tert-butyl ester, and the α-carboxyl group remains free. Packing: 1kg/bag,25kg/drum or as request Availability: In stock
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1].Wiejak S, Masiukiewicz E, Rzeszotarska B. A large scale synthesis of mono- and di-urethane derivatives of lysine. Chem Pharm Bull (Tokyo). 1999;47(10):1489–90. doi: 10.1248/cpb.47.1489.
[2].Berkers CR, de Jong A, Schuurman KG, Linnemann C, Geenevasen JAJ, Schumacher TNM, et al. Peptide splicing in the proteasome creates a novel type of antigen with an isopeptide linkage. J Immunol. 2015;195(9):4075–84. doi: 10.4049/jimmunol.1402454.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.